CytoDyn has previously submitted applications for
CytoDyn has previously submitted applications for Breakthrough Therapy Designation (BTD) for their drug leronlimab (PRO 140) for the treatment of metastatic triple-negative breast cancer (mTNBC).
Here is a summary of the status based on available public information:
Submissions: CytoDyn filed for BTD for leronlimab in mTNBC multiple times, including an initial filing in January 2020 and a subsequent submission or re-submission in November 2021.
FDA Response: There is no recent public confirmation that the FDA has granted the Breakthrough Therapy Designation for leronlimab for mTNBC.
Current Focus: CytoDyn continues to develop leronlimab in oncology, and recent press releases (late 2024 and 2025) focus on:
FDA clearance to proceed with a Phase 2 oncology trial for leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer (mCRC).
New data analyses suggesting a novel mechanism of action for leronlimab in solid tumors, specifically in mTNBC patients.
In summary:
CytoDyn has sought Breakthrough Therapy Designation for leronlimab in mTNBC in the past, but the most recent public information available does not indicate that the designation has been granted. The company's current activities appear to be focused on advancing their Phase 2 oncology trials for other solid tumors, such as colorectal cancer, and ongoing analysis of data in mTNBC.
What is Breakthrough Therapy Designation?
Breakthrough Therapy Designation is a process created by the FDA to expedite the development and review of a drug if it is intended to treat a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate a substantial improvement over available therapies on a clinically significant endpoint.
A company must submit a formal request with supporting preliminary clinical data to the FDA for the drug and specific indication to be considered. The designation, if granted, provides for more intensive FDA guidance and an organizational commitment involving senior managers to expedite the drug's development.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dividend Hike: A Sign of Strength When a company like Aflac, with its sprawling presence both in the U.S. and Japan, decides to hike its dividend, it says a lot more than any quarterly report ever could. They just announced a 4.9% bump in the first quarter 2027 dividend, pushing it to $0.64 per share. You better believe this isn't just a pat on the back for their...
Continue Reading
Diving into Kroll's New Geoeconomic Risk Index When global storms brew, businesses yearn for a reliable compass. In swoops Kroll with its Geoeconomic Risk Index—a new tool aimed at taking the mystique out of geopolitical and economic uncertainties to forecast their impact on businesses' bottom lines. Understanding the Index This isn't just another fancy gadget for the...
Continue Reading
Spotlight on Ardelyx: The Legal Smoke Signal Ah, lawsuits. They're like bad weather for companies—sometimes, you know they're coming, and they still hit you hard. Ardelyx's investors who've been in the game from January 13, 2025, to August 6, 2026, are now dealing with just such a storm. What's the Lawsuit Racket? Faruqi & Faruqi, LLP, a securities law firm that seems...
Continue Reading
QFIN Executives in Legal Hot Water Qfin Holdings, Inc. (NASDAQ: QFIN) is in a tight spot as a securities class action lawsuit casts a harsh spotlight on its senior executives. The CEO and CFO, during the contested class period, are front and center in this legal tangle. Qfin's stockholders are grappling with losses, and it's all tied back to some certified SEC filings...
Continue Reading
Meola's Strategic Move to Quandary Peak Some folks got a knack for solving more than just ordinary puzzles, and Matthew Meola happens to be one of them. This guy's spent 13 years knee-deep in litigation consulting, wrangling with the big boys over patent, software copyright, and trade secret disputes. Now, he's teamed up with Quandary Peak Research, and it's not just any...
Continue Reading
Florida's Call for Safeguarding Kids Online You know, it's not every day you see a political agreement that can unite parents regardless of which side of the fence they're on, but this one seems to be doing the trick. The call for better online safety measures for kids in Florida is gaining serious muscle, with two-thirds of parents backing the state's participation in a...
Continue Reading
Innovative Twist on a Common Household Item Most folks don't give a second thought to the humble wall plate. It's just something you see, not something you think about until—bam!—sparks fly. But here's the scribble from a couple of bright minds down in Elko, Nev.: they've cooked up something called the SAFE WALL PLATE. Their goal? To patch up a glaring safety flaw...
Continue Reading
Thailand's Wellness Economy Flexes its Muscles When your economy grows at a clip of 8.8% in a single year, folks in the investment world start raising their eyebrows, and Thailand’s been doing just that with its booming wellness sector. In 2025, the numbers came rolling in, tall and proud, marking Thailand’s wellness economy at a hefty $46.5 billion. This is not just...
Continue Reading
Voyageurs' Skyward Triumph: A Stellar Win for Conservation Ah, the night sky. That vast, galaxy-speckled canvas we too often ignore, drowned out by urban light pollution. But hey, not in Voyageurs National Park, no sir. This gem's just snagged the 2026 International Dark Sky Place of the Year Award, handed out by those watchful folks at DarkSky International. It's a...
Continue Reading
UMG Steps into the Spotlight at Morgan Stanley Event Music, money, and technology—it's a compelling trio. Universal Music Group (EURONEXT: UMG) is sending its heavyweights, Matt Ellis and Michael Nash, to the Morgan Stanley European Technology, Media & Telecom Conference on November 18, 2026. This isn't just any run-of-the-mill industry hobnob. We're talking about the...
Continue Reading
Top 5 Most Recently Viewed Articles
Paycor HCM, Inc. Announces Tiffany Sieve as New CMO Paycor HCM, Inc. (Nasdaq: PYCR), a leading provider of human capital management software, has officially promoted Tiffany Sieve to the position of Chief Marketing Officer. In her new role, Sieve is set to play a crucial part in steering the company towards its ambitious goal of reaching $1 billion in revenue. She will...
Continue Reading
Exciting Prizes Await in BTCC Exchange's Halloween Campaign BTCC, the exceedingly reputable cryptocurrency exchange, has introduced an exhilarating campaign to celebrate Halloween, known as the Spooktacular Halloween Night of Fortune. This unique initiative, running from October 24 to October 31, invites participants to engage in futures trading while unlocking impressive...
Continue Reading
ASM Capital Group's Vision for American Whiskey Today, ASM Capital Group, a leader in spirit investments, is excited to announce the launch of the ASM Capital Whiskey Fund. This unique fund is specifically focused on promoting the American Single Malt Whiskey category, a designation recently recognized by The Alcohol and Tobacco Tax and Trade Bureau (TTB). The ASM Capital...
Continue Reading
Navigate Tax Season Smoothly with W-2 Insights As tax season approaches, it becomes increasingly crucial for employees to understand their Form W-2, officially known as the Wage and Tax Statement. This document is essential when reporting income and tax withholdings to the IRS. With the 2024 Form W-2 deadline fast approaching, it is vital to thoroughly review this form...
Continue Reading
GlobalPlatform Aims to Streamline IoT Security Compliance In an ever-evolving digital landscape, GlobalPlatform is urging manufacturers of connected devices to adopt its innovative "Security Evaluation Standard for IoT Platforms" (SESIP) methodology. This initiative aims to assist in meeting the stringent requirements set forth by the European Union’s new Cyber...
Continue Reading